Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis

Background and aimsBody composition parameters and immunonutritional indexes provide useful information on the nutritional and inflammatory status of patients. We sought to investigate whether they predict the postoperative outcome in patients with pancreatic cancer (PC) who received neoadjuvant the...

Full description

Bibliographic Details
Main Authors: Salvatore Paiella, Danila Azzolina, Ilaria Trestini, Giuseppe Malleo, Gennaro Nappo, Claudio Ricci, Carlo Ingaldi, Pier Giuseppe Vacca, Matteo De Pastena, Erica Secchettin, Giulia Zamboni, Laura Maggino, Maria Assunta Corciulo, Marta Sandini, Marco Cereda, Giovanni Capretti, Riccardo Casadei, Claudio Bassi, Giancarlo Mansueto, Dario Gregori, Michele Milella, Alessandro Zerbi, Luca Gianotti, Roberto Salvia
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1065294/full
_version_ 1827943067294892032
author Salvatore Paiella
Danila Azzolina
Ilaria Trestini
Giuseppe Malleo
Gennaro Nappo
Gennaro Nappo
Claudio Ricci
Claudio Ricci
Carlo Ingaldi
Carlo Ingaldi
Pier Giuseppe Vacca
Matteo De Pastena
Erica Secchettin
Giulia Zamboni
Laura Maggino
Maria Assunta Corciulo
Marta Sandini
Marco Cereda
Giovanni Capretti
Giovanni Capretti
Riccardo Casadei
Riccardo Casadei
Claudio Bassi
Giancarlo Mansueto
Dario Gregori
Michele Milella
Alessandro Zerbi
Alessandro Zerbi
Luca Gianotti
Roberto Salvia
author_facet Salvatore Paiella
Danila Azzolina
Ilaria Trestini
Giuseppe Malleo
Gennaro Nappo
Gennaro Nappo
Claudio Ricci
Claudio Ricci
Carlo Ingaldi
Carlo Ingaldi
Pier Giuseppe Vacca
Matteo De Pastena
Erica Secchettin
Giulia Zamboni
Laura Maggino
Maria Assunta Corciulo
Marta Sandini
Marco Cereda
Giovanni Capretti
Giovanni Capretti
Riccardo Casadei
Riccardo Casadei
Claudio Bassi
Giancarlo Mansueto
Dario Gregori
Michele Milella
Alessandro Zerbi
Alessandro Zerbi
Luca Gianotti
Roberto Salvia
author_sort Salvatore Paiella
collection DOAJ
description Background and aimsBody composition parameters and immunonutritional indexes provide useful information on the nutritional and inflammatory status of patients. We sought to investigate whether they predict the postoperative outcome in patients with pancreatic cancer (PC) who received neoadjuvant therapy (NAT) and then pancreaticoduodenectomy.MethodsData from locally advanced PC patients who underwent NAT followed by pancreaticoduodenectomy between January 2012 and December 2019 in four high-volume institutions were collected retrospectively. Only patients with two available CT scans (before and after NAT) and immunonutritional indexes (before surgery) available were included. Body composition was assessed and immunonutritional indexes collected were: VAT, SAT, SMI, SMA, PLR, NLR, LMR, and PNI. The postoperative outcomes evaluated were overall morbidity (any complication occurring), major complications (Clavien-Dindo ≥ 3), and length of stay.ResultsOne hundred twenty-one patients met the inclusion criteria and constituted the study population. The median age at the diagnosis was 64 years (IQR16), and the median BMI was 24 kg/m2 (IQR 4.1). The median time between the two CT-scan examined was 188 days (IQR 48). Skeletal muscle index (SMI) decreased after NAT, with a median delta of −7.8 cm2/m2 (p < 0.05). Major complications occurred more frequently in patients with a lower pre-NAT SMI (p = 0.035) and in those who gained in subcutaneous adipose tissue (SAT) compartment during NAT (p = 0.043). Patients with a gain in SMI experienced fewer major postoperative complications (p = 0.002). The presence of Low muscle mass after NAT was associated with a longer hospital stay [Beta 5.1, 95%CI (1.5, 8.7), p = 0.006]. An increase in SMI from 35 to 40 cm2/m2 was a protective factor with respect to overall postoperative complications [OR 0.43, 95% (CI 0.21, 0.86), p < 0.001]. None of the immunonutritional indexes investigated predicted the postoperative outcome.ConclusionBody composition changes during NAT are associated with surgical outcome in PC patients who receive pancreaticoduodenectomy after NAT. An increase in SMI during NAT should be favored to ameliorate the postoperative outcome. Immunonutritional indexes did not show to be capable of predicting the surgical outcome.
first_indexed 2024-03-13T10:09:51Z
format Article
id doaj.art-c5215ff322ea4a988a2236381f6507d4
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-03-13T10:09:51Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-c5215ff322ea4a988a2236381f6507d42023-05-22T07:03:17ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-02-011010.3389/fnut.2023.10652941065294Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysisSalvatore Paiella0Danila Azzolina1Ilaria Trestini2Giuseppe Malleo3Gennaro Nappo4Gennaro Nappo5Claudio Ricci6Claudio Ricci7Carlo Ingaldi8Carlo Ingaldi9Pier Giuseppe Vacca10Matteo De Pastena11Erica Secchettin12Giulia Zamboni13Laura Maggino14Maria Assunta Corciulo15Marta Sandini16Marco Cereda17Giovanni Capretti18Giovanni Capretti19Riccardo Casadei20Riccardo Casadei21Claudio Bassi22Giancarlo Mansueto23Dario Gregori24Michele Milella25Alessandro Zerbi26Alessandro Zerbi27Luca Gianotti28Roberto Salvia29General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyDepartment of Environmental and Preventive Science, University of Ferrara, Ferrara, ItalyDietetics Services, Hospital Medical Direction, University Hospital Trust of Verona, Verona, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyIRCCS Humanitas Research Hospital, Rozzano, ItalyPancreatic Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItalyDepartment of Internal Medicine and Surgery (DIMEC), S. Orsola-Malpighi Hospital, University of Bologna, Bologna, ItalyPancreatic Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItalyDepartment of Internal Medicine and Surgery (DIMEC), S. Orsola-Malpighi Hospital, University of Bologna, Bologna, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyRadiology Unit, Pancreas Institute, University of Verona, Verona, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyUnit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy0General Surgery Unit, University of Siena, Siena, Italy1School of Medicine and Surgery, University of Milano-Bicocca and HPB Unit, San Gerardo Hospital Monza, Monza, ItalyDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyIRCCS Humanitas Research Hospital, Rozzano, ItalyPancreatic Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItalyDepartment of Internal Medicine and Surgery (DIMEC), S. Orsola-Malpighi Hospital, University of Bologna, Bologna, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyRadiology Unit, Pancreas Institute, University of Verona, Verona, ItalyUnit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy2Section of Oncology, Department of Medicine, University of Verona Hospital Trust, Verona, ItalyDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyIRCCS Humanitas Research Hospital, Rozzano, Italy1School of Medicine and Surgery, University of Milano-Bicocca and HPB Unit, San Gerardo Hospital Monza, Monza, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, ItalyBackground and aimsBody composition parameters and immunonutritional indexes provide useful information on the nutritional and inflammatory status of patients. We sought to investigate whether they predict the postoperative outcome in patients with pancreatic cancer (PC) who received neoadjuvant therapy (NAT) and then pancreaticoduodenectomy.MethodsData from locally advanced PC patients who underwent NAT followed by pancreaticoduodenectomy between January 2012 and December 2019 in four high-volume institutions were collected retrospectively. Only patients with two available CT scans (before and after NAT) and immunonutritional indexes (before surgery) available were included. Body composition was assessed and immunonutritional indexes collected were: VAT, SAT, SMI, SMA, PLR, NLR, LMR, and PNI. The postoperative outcomes evaluated were overall morbidity (any complication occurring), major complications (Clavien-Dindo ≥ 3), and length of stay.ResultsOne hundred twenty-one patients met the inclusion criteria and constituted the study population. The median age at the diagnosis was 64 years (IQR16), and the median BMI was 24 kg/m2 (IQR 4.1). The median time between the two CT-scan examined was 188 days (IQR 48). Skeletal muscle index (SMI) decreased after NAT, with a median delta of −7.8 cm2/m2 (p < 0.05). Major complications occurred more frequently in patients with a lower pre-NAT SMI (p = 0.035) and in those who gained in subcutaneous adipose tissue (SAT) compartment during NAT (p = 0.043). Patients with a gain in SMI experienced fewer major postoperative complications (p = 0.002). The presence of Low muscle mass after NAT was associated with a longer hospital stay [Beta 5.1, 95%CI (1.5, 8.7), p = 0.006]. An increase in SMI from 35 to 40 cm2/m2 was a protective factor with respect to overall postoperative complications [OR 0.43, 95% (CI 0.21, 0.86), p < 0.001]. None of the immunonutritional indexes investigated predicted the postoperative outcome.ConclusionBody composition changes during NAT are associated with surgical outcome in PC patients who receive pancreaticoduodenectomy after NAT. An increase in SMI during NAT should be favored to ameliorate the postoperative outcome. Immunonutritional indexes did not show to be capable of predicting the surgical outcome.https://www.frontiersin.org/articles/10.3389/fnut.2023.1065294/fullpancreatic cancernutrition–clinicalbody compositionpostoperative complicationsinflammation
spellingShingle Salvatore Paiella
Danila Azzolina
Ilaria Trestini
Giuseppe Malleo
Gennaro Nappo
Gennaro Nappo
Claudio Ricci
Claudio Ricci
Carlo Ingaldi
Carlo Ingaldi
Pier Giuseppe Vacca
Matteo De Pastena
Erica Secchettin
Giulia Zamboni
Laura Maggino
Maria Assunta Corciulo
Marta Sandini
Marco Cereda
Giovanni Capretti
Giovanni Capretti
Riccardo Casadei
Riccardo Casadei
Claudio Bassi
Giancarlo Mansueto
Dario Gregori
Michele Milella
Alessandro Zerbi
Alessandro Zerbi
Luca Gianotti
Roberto Salvia
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
Frontiers in Nutrition
pancreatic cancer
nutrition–clinical
body composition
postoperative complications
inflammation
title Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
title_full Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
title_fullStr Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
title_full_unstemmed Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
title_short Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
title_sort body composition parameters immunonutritional indexes and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy a retrospective multicenter analysis
topic pancreatic cancer
nutrition–clinical
body composition
postoperative complications
inflammation
url https://www.frontiersin.org/articles/10.3389/fnut.2023.1065294/full
work_keys_str_mv AT salvatorepaiella bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT danilaazzolina bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT ilariatrestini bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT giuseppemalleo bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT gennaronappo bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT gennaronappo bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT claudioricci bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT claudioricci bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT carloingaldi bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT carloingaldi bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT piergiuseppevacca bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT matteodepastena bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT ericasecchettin bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT giuliazamboni bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT lauramaggino bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT mariaassuntacorciulo bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT martasandini bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT marcocereda bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT giovannicapretti bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT giovannicapretti bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT riccardocasadei bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT riccardocasadei bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT claudiobassi bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT giancarlomansueto bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT dariogregori bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT michelemilella bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT alessandrozerbi bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT alessandrozerbi bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT lucagianotti bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis
AT robertosalvia bodycompositionparametersimmunonutritionalindexesandsurgicaloutcomeofpancreaticcancerpatientsresectedafterneoadjuvanttherapyaretrospectivemulticenteranalysis